HOLLY WRIGHT: Open Payments
NPI 1255979191 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 22 payments from 11 companies in 2025. Trend: 2023 $74 · 2024 $777 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $147 |
| SHIELD THERAPEUTICS INC | 2 | $51 |
| Novo Nordisk Inc | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Acella Pharmaceuticals, LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Korlym, ACCRUFER, Kerendia, NP Thyroid 60, Ozempic, INSPIRE, ISTURISA, FARXIGA.
Industry payments across UT — which companies pay providers there.
